Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, 40225, Germany
Location status: Recruiting
NCT Number: NCT02728479
Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease.
The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Düsseldorf, 40225, Germany
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Time frame: 2 Days after PTA
Time frame: 30 days
Time frame: 12 months
Days of Hospitalization at 12 months
Time frame: 6 months and 12 months
Clinical Improvement measured by Ankle-Brachial Index
Time frame: 6 months and 12 months
Clinical Improvement measured by walking distance
Time frame: 12 months
Percentage of patients with restenosis at 12 months
Interested in participating?
Request InfoKlinik für Kardiologie, Pneumologie und Angiologie
Other
PTA Registry - an Observational Study of Percutaneous Transluminal Angioplasty
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07312383
Arterial Occlusive Diseases, Arteriosclerosis
Oslo, Norway
View Trial DetailsNCT05834803
Cardiovascular Diseases, Female Urogenital Diseases
Aarhus N, Denmark
View Trial DetailsNCT02593994
Arterial Occlusive Diseases, Arteriosclerosis
Seoul, Republic of Korea, South Korea
View Trial DetailsNCT05217459
Brain Diseases, Cardiovascular Diseases
Beijing, China
View Trial Details